scholarly journals Roles of the Polyphenol–Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer

2020 ◽  
Author(s):  
Yiying Zhao ◽  
Qing Jiang
Keyword(s):  
Colorectal Cancer ◽  
Animal Models ◽  
Gut Microbiota ◽  
Animal Studies ◽  
Future Research ◽  
Protective Effects ◽  
Microbial Composition ◽  
Dietary Polyphenols ◽  
Inflammatory Conditions ◽  
Opportunistic Pathogenic

ABSTRACT Accumulating evidence indicates that the gut microbiota can promote or inhibit colonic inflammation and carcinogenesis. Promotion of beneficial gut bacteria is considered a promising strategy to alleviate colonic diseases including colitis and colorectal cancer. Interestingly, dietary polyphenols, which have been shown to attenuate colitis and inhibit colorectal cancer in animal models and some human studies, appear to reach relatively high concentrations in the large intestine and to interact with the gut microbial community. This review summarizes the modulatory effects of polyphenols on the gut microbiota in humans and animals under healthy and diseased conditions including colitis and colitis-associated colorectal cancer (CAC). Existing human and animal studies indicate that polyphenols and polyphenol-rich whole foods are capable of elevating butyrate producers and probiotics that alleviate colitis and inhibit CAC, such as Lactobacillus and Bifidobacterium. Studies in colitis and CAC models indicate that polyphenols decrease opportunistic pathogenic or proinflammatory microbes and counteract disease-induced dysbiosis. Consistently, polyphenols also change microbial functions, including increasing butyrate formation. Moreover, polyphenol metabolites produced by the gut microbiota appear to have anticancer and anti-inflammatory activities, protect gut barrier integrity, and mitigate inflammatory conditions in cells and animal models. Based on these results, we conclude that polyphenol-mediated alteration of microbial composition and functions, together with polyphenol metabolites produced by the gut microbiota, likely contribute to the protective effects of polyphenols on colitis and CAC. Future research is needed to validate the causal role of the polyphenol–gut microbiota interaction in polyphenols’ anti-colitis and anti-CAC effects, and to further elucidate mechanisms underlying such interaction.

scholarly journals Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery

Life ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 246
Author(s):  
Felix C.F. Schmitt ◽  
Martin Schneider ◽  
William Mathejczyk ◽  
Markus A. Weigand ◽  
Jane C. Figueiredo ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Postoperative Complications ◽  
Gut Microbiota ◽  
Gut Microbiome ◽  
Tumor Resection ◽  
Microbial Composition ◽  
Colorectal Cancer Surgery ◽  
Long Term Changes ◽  
Stool Samples

Changes in the gut microbiome have already been associated with postoperative complications in major abdominal surgery. However, it is still unclear whether these changes are transient or a long-lasting effect. Therefore, the aim of this prospective clinical pilot study was to examine long-term changes in the gut microbiota and to correlate these changes with the clinical course of the patient. Methods: In total, stool samples of 62 newly diagnosed colorectal cancer patients undergoing primary tumor resection were analyzed by 16S-rDNA next-generation sequencing. Stool samples were collected preoperatively in order to determine the gut microbiome at baseline as well as at 6, 12, and 24 months thereafter to observe longitudinal changes. Postoperatively, the study patients were separated into two groups—patients who suffered from postoperative complications (n = 30) and those without complication (n = 32). Patients with postoperative complications showed a significantly stronger reduction in the alpha diversity starting 6 months after operation, which does not resolve, even after 24 months. The structure of the microbiome was also significantly altered from baseline at six-month follow-up in patients with complications (p = 0.006). This was associated with a long-lasting decrease of a large number of species in the gut microbiota indicating an impact in the commensal microbiota and a long-lasting increase of Fusobacterium ulcerans. The microbial composition of the gut microbiome shows significant changes in patients with postoperative complications up to 24 months after surgery.

Diabetes diminishes typical metabolite of litchi pericarp oligomeric procyanidins (LPOPC) in urine mediated by imbalanced gut microbiota

2021 ◽  
Author(s):  
Xiaopeng Li ◽  
Yong Sui ◽  
B. Xie ◽  
Zhida Sun ◽  
Shuyi Li
Keyword(s):  
Clinical Trials ◽  
Gut Microbiota ◽  
Animal Studies ◽  
Dietary Polyphenols ◽  
Litchi Pericarp

Animal studies and clinical trials have shown that dietary polyphenols and polyphenol-rich foods can reduce the risk of T2D and its complications, but how diabetes regulates the metabolism of polyphenol...

scholarly journals Gut Microbiota, Fusobacteria, and Colorectal Cancer

Diseases ◽  
2018 ◽  
Vol 6 (4) ◽  
pp. 109 ◽  
Author(s):  
Dervla Kelly ◽  
Liying Yang ◽  
Zhiheng Pei
Keyword(s):  
Colorectal Cancer ◽  
Gut Microbiota ◽  
Inflammatory Responses ◽  
Tumor Development ◽  
Host Responses ◽  
Future Research ◽  
Bacterial Microbiota ◽  
Promote Tumor Growth ◽  
Tumor Environment ◽  
Protective Strategies

The gut microbiota has emerged as an environmental contributor to colorectal cancer (CRC) in both animal models and human studies. It is now generally accepted that bacteria are ubiquitous colonizers of all exposed human body surfaces, including the entire alimentary tract (5). Recently, the concept that a normal bacterial microbiota is essential for the development of inflammation-induced carcinoma has emerged from studies of well-known colonic bacterial microbiota. This review explores the evidence for a role of fusobacteria, an anaerobic gram-negative bacterium that has repeatedly been detected at colorectal tumor sites in higher abundance than surrounding histologically normal tissue. Mechanistic studies provide insight on the interplay between fusobacteria, other gut microbiota, barrier functions, and host responses. Studies have shown that fusobacteria activate host inflammatory responses designed to protect against pathogens that promote tumor growth. We discuss how future research identifying the pathophysiology underlying fusobacteria colon colonization during colorectal cancer may lead to new therapeutic targets for cancer. Furthermore, disease-protective strategies suppressing tumor development by targeting the local tumor environment via bacteria represent another exciting avenue for researchers and are highlighted in this review.

scholarly journals Immunological and Pathophysiological Outcomes of Helminth Infections and Type 2 Diabetes Comorbidity Studies in Humans and Experimental Animals—A Scoping Review

2021 ◽  
Vol 11 (17) ◽  
pp. 8079
Author(s):  
Ekuyikeno Silas ◽  
Siyanda Ndlovu ◽  
Selaelo Ivy Tshilwane ◽  
Samson Mukaratirwa
Keyword(s):  
Type 2 Diabetes ◽  
Immune Modulation ◽  
Animal Studies ◽  
Developed Countries ◽  
Laboratory Animals ◽  
Future Research ◽  
Protective Effects ◽  
Degree Of Protection ◽  
Helminth Infections

Animal and human studies have demonstrated that helminth infections are associated with a decreased prevalence of type 2 diabetes mellitus (T2DM). Lack of exposure to helminth infections has been postulated to be one mechanism to explain the markedly increased prevalence of T2DM in developed countries. However, there is still paucity of information regarding the immunological interactions between helminth infections and T2DM. The study aimed at reviewing peer-reviewed articles on host immune and pathophysiological outcomes from human and laboratory animal studies of helminth infections and T2DM comorbidity. A literature search was carried out in Google Scholar, PubMed, and EBSCOhost databases using the following keywords; immune responses OR immune modulation of helminth infections OR parasites infections AND Type 2 diabetes comorbidity in humans AND experimental/laboratory animals. Results showed that helminth infections provided some degree of protection from the pathology associated with T2DM by modulating the surrounding cytokine and chemokine milieu in humans and animals. Whilst there is some evidence regarding the protective effects of helminth infections to T2DM in cases of comorbidity, there is paucity of research in both laboratory animals and humans, with reference to the immunological and pathophysiological mechanisms which occur during comorbidity, and these constitute gaps for future research.

scholarly journals Impact of Nutrition on Pulmonary Arterial Hypertension

Nutrients ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 169
Author(s):  
María Callejo ◽  
Joan Albert Barberá ◽  
Juan Duarte ◽  
Francisco Perez-Vizcaino
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Animal Models ◽  
Gut Microbiota ◽  
Arterial Hypertension ◽  
Case Reports ◽  
Host Immune System ◽  
Dietary Polyphenols ◽  
Pulmonary Arterial ◽  
Near Future

Pulmonary arterial hypertension (PAH) is characterized by sustained vasoconstriction, vascular remodeling, inflammation, and in situ thrombosis. Although there have been important advances in the knowledge of the pathophysiology of PAH, it remains a debilitating, limiting, and rapidly progressive disease. Vitamin D and iron deficiency are worldwide health problems of pandemic proportions. Notably, these nutritional alterations are largely more prevalent in PAH patients than in the general population and there are several pieces of evidence suggesting that they may trigger or aggravate disease progression. There are also several case reports associating scurvy, due to severe vitamin C deficiency, with PAH. Flavonoids such as quercetin, isoflavonoids such as genistein, and other dietary polyphenols including resveratrol slow the progression of the disease in animal models of PAH. Finally, the role of the gut microbiota and its interplay with the diet, host immune system, and energy metabolism is emerging in multiple cardiovascular diseases. The alteration of the gut microbiota has also been reported in animal models of PAH. It is thus possible that in the near future interventions targeting the nutritional status and the gut dysbiosis will improve the outcome of these patients.

scholarly journals Interaction with Gut Microbiota Plays a Causative Role in Grape Powder-Mediated Anti-Colitis Effects in Mice

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 499-499
Author(s):  
Yiying Zhao ◽  
Qing Jiang
Keyword(s):  
Gut Microbiota ◽  
Rectal Bleeding ◽  
Tissue Damage ◽  
Control Diet ◽  
Spleen Weight ◽  
Causative Role ◽  
Protective Effects ◽  
Gut Health ◽  
Colonic Tissue ◽  
Microbial Composition

Abstract Objectives Gut microbiota is recognized to play a regulatory role in gut health and diseases. Previously, in a mouse model of colitis-associated colorectal cancer, we found that 10% grape powder (10GP) diet, which contains 0.033% polyphenols, attenuated colitis symptoms and restored colitis-changed gut microbial composition. However, it is not clear whether microbial modulation by 10GP directly contributes to the observed protective effects. To address the question, we compared the effect of 10GP on colitis in the presence and absence of antibiotics in mice. Methods Male Balb/c mice were gavaged with either water or antibiotic cocktail (ABX) daily for 7 days. For both water and ABX-treated mice, we further divided them into three subgroups: 1) healthy control (non-DSS), 2) mice fed with control diet and treated by 1.8% dextran sodium sulfate (DSS) in drinking water, and 3) mice fed with 10GP diet and treated with DSS (DSS-10GP). During the study, we monitored mice’ body weight and evaluated their colitis symptoms including stool consistency and rectal bleeding. All mice were sacrificed 9–10 days after DSS administration. Results Compared with conventional mice, ABX-treated mice had lowered liver and colon weight, increased level of fecal acetate and decreased levels of fecal butyrate and propionate. For both conventional and ABX-treated mice, DSS treatment caused colitis symptoms including rectal bleeding and diarrhea, colonic tissue damage, increased spleen weight and shortened colon length. Importantly, 10GP significantly alleviated DSS-induced colitis symptoms in non-ABX conventional mice, as indicated by attenuated fecal bleeding and diarrhea, reduced colonic tissue damage, and lowered spleen weight and colon weight to length ratio as inflammatory indexes. In contrast, these protective effects of 10GP were not observed in the ABX-treated mice. Conclusions 10GP diet showed protective effects against DSS-induced colitis in conventional mice, but not ABX-treated mice. This observation indicates that interaction between 10GP and gut microbiota plays a causative role in 10GP-mediated protective effects on colitis. Funding Sources California Table Grape Commission.

scholarly journals Olive Oil Effects on Colorectal Cancer

Nutrients ◽  
2018 ◽  
Vol 11 (1) ◽  
pp. 32 ◽  
Author(s):  
Antonio Borzì ◽  
Antonio Biondi ◽  
Francesco Basile ◽  
Salvatore Luca ◽  
Enzo Vicari ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Gut Microbiota ◽  
Olive Oil ◽  
Mediterranean Diet ◽  
Protective Action ◽  
Chemotherapeutic Agents ◽  
Oil Consumption ◽  
Active Metabolites ◽  
Microbial Composition ◽  
Beneficial Effects

Colorectal cancer is the fourth cause of cancer-related death worldwide. A Mediterranean diet showed protective action against colorectal cancer due to the intake of different substances. Olive oil is a fundamental component of the Mediterranean diet. Olive oil is rich in high-value health compounds (such as monounsaturated free fatty acids, squalene, phytosterols, and phenols). Phenolic compounds exert favourable effects on free radicals, inflammation, gut microbiota, and carcinogenesis. The interaction between gut microbiota and olive oil consumption could modulate colonic microbial composition or activity, with a possible role in cancer prevention. Gut microbiota is able to degrade some substances found in olive oil, producing active metabolites with chemopreventive action. Further clinical research is needed to clarify the beneficial effects of olive oil and its components. A better knowledge of the compounds found in olive oil could lead to the development of nutritional supplements or chemotherapeutic agents with a potential in the prevention and treatment of colorectal cancer.

scholarly journals Prebiotics from Seaweeds: An Ocean of Opportunity?

Marine Drugs ◽  
2019 ◽  
Vol 17 (6) ◽  
pp. 327 ◽  
Author(s):  
Paul Cherry ◽  
Supriya Yadav ◽  
Conall R. Strain ◽  
Philip J. Allsopp ◽  
Emeir M. McSorley ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Gut Microbiota ◽  
Animal Studies ◽  
Health Benefit ◽  
Microbial Composition ◽  
Previous Discussion ◽  
Host Health ◽  
Health Related

Seaweeds are an underexploited and potentially sustainable crop which offer a rich source of bioactive compounds, including novel complex polysaccharides, polyphenols, fatty acids, and carotenoids. The purported efficacies of these phytochemicals have led to potential functional food and nutraceutical applications which aim to protect against cardiometabolic and inflammatory risk factors associated with non-communicable diseases, such as obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, inflammatory bowel disease, and some cancers. Concurrent understanding that perturbations of gut microbial composition and metabolic function manifest throughout health and disease has led to dietary strategies, such as prebiotics, which exploit the diet-host-microbe paradigm to modulate the gut microbiota, such that host health is maintained or improved. The prebiotic definition was recently updated to “a substrate that is selectively utilised by host microorganisms conferring a health benefit”, which, given that previous discussion regarding seaweed prebiotics has focused upon saccharolytic fermentation, an opportunity is presented to explore how non-complex polysaccharide components from seaweeds may be metabolised by host microbial populations to benefit host health. Thus, this review provides an innovative approach to consider how the gut microbiota may utilise seaweed phytochemicals, such as polyphenols, polyunsaturated fatty acids, and carotenoids, and provides an updated discussion regarding the catabolism of seaweed-derived complex polysaccharides with potential prebiotic activity. Additional in vitro screening studies and in vivo animal studies are needed to identify potential prebiotics from seaweeds, alongside untargeted metabolomics to decipher microbial-derived metabolites from seaweeds. Furthermore, controlled human intervention studies with health-related end points to elucidate prebiotic efficacy are required.

scholarly journals Role of Gut Microbiota in Hepatocarcinogenesis

2019 ◽  
Vol 7 (5) ◽  
pp. 121 ◽  
Author(s):  
Haripriya Gupta ◽  
Gi Soo Youn ◽  
Min Jea Shin ◽  
Ki Tae Suk
Keyword(s):  
Gut Microbiota ◽  
Animal Studies ◽  
Intestinal Barrier ◽  
Intestinal Microbiome ◽  
Future Research ◽  
Pathophysiological Mechanism ◽  
Microbial Dysbiosis ◽  
Gut Barrier Function ◽  
Hepatic Diseases ◽  
Causal Nexus

Hepatocellular carcinoma (HCC), one of the leading causes of death worldwide, has a causal nexus with liver injury, inflammation, and regeneration that accumulates over decades. Observations from recent studies have accounted for the involvement of the gut–liver axis in the pathophysiological mechanism responsible for HCC. The human intestine nurtures a diversified colony of microorganisms residing in the host ecosystem. The intestinal barrier is critical for conserving the normal physiology of the gut microbiome. Therefore, a rupture of this barrier or dysbiosis can cause the intestinal microbiome to serve as the main source of portal-vein endotoxins, such as lipopolysaccharide, in the progression of hepatic diseases. Indeed, increased bacterial translocation is a key sign of HCC. Considering the limited number of clinical studies on HCC with respect to the microbiome, we focus on clinical as well as animal studies involving the gut microbiota, with the current understandings of the mechanism by which the intestinal dysbiosis promotes hepatocarcinogenesis. Future research might offer mechanistic insights into the specific phyla targeting the leaky gut, as well as microbial dysbiosis, and their metabolites, which represent key pathways that drive HCC-promoting microbiome-mediated liver inflammation and fibrosis, thereby restoring the gut barrier function.

Sign in / Sign up

Export Citation Format

Share Document